Overview

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of fenretinide may prevent ovarian cancer. PURPOSE: This randomized clinical trial is studying how well fenretinide works in preventing ovarian cancer in participants who are at high risk of developing ovarian cancer and planning to undergo surgery to remove the ovaries.

Phase:

N/A

Details

Lead Sponsor:

University of Arizona

Collaborator:

National Cancer Institute (NCI)

Treatments:

Fenretinide